YannTong Chiang

1 ta ish

Novartis (United States)

1. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial

   George L. Bakris, Pantelis Sarafidis, Matthew R Weir +9

   Maqola20103 iqtibos

   ABIABI:AkademIndex/2026.other.535137